A targeted drug-delivery system called TAMP aims to send chemotherapy near pancreatic tumors instead of through the entire ...
Jazz announced U.S. FDA acceptance with Priority Review of Supplemental Biologics License Application (sBLA) for zanidatamab in first-line HER2-positive unresectable locally advanced or metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results